Outsourcing-Pharma’s Post

🌟 Empowering Women in Science: A Conversation with Vaxess CEO, Rachel Sha 🌟 In today’s BioPharma-Reporter feature, we dive into the journey of Rachel Sha, CEO of Vaxess Technologies, as she discusses what it means to own your seat at the table in the world of biotech. Rachel shares valuable insights on leadership, navigating challenges, and the pivotal role of women in shaping the future of science and innovation. Whether you're in science, leadership, or simply looking for inspiration, this article is a must-read! 👩🔬 🔗 Read more here: https://lnkd.in/eNdaF2-j #WomenInSTEM #BiotechLeadership #WomenInScience #OutsourcingPharma #STEMLeadership #Innovation

If we can see it, we can be it! So, thank you Fierce Pharma for featuring these amazing female role models in your latest report. Explore the profiles of 10 of the fiercest women in life sciences who are spearheading Big Pharma business development, guiding up-and-coming biotechs and leading clinical research into potentially lifesaving technologies and therapeutics! #FemaleLeaders #FemaleVisibility

I love to see articles like these from Fierce Pharma. I have learned a ton from women in Biotechnology - I know a ton who should be nominated soon like Alison Kyle Handel, MS (Quest Diagnostics), Patricia Judson, Sohanya Cheng, MA, MBA from Karyopharm Therapeutics Inc., Reshma Rangwala (CMO), Valerie Kobzej from Bristol Myers Squibb, Jen Maurer from Legend Biotech, and of course Michele Korfin (whom I hope takes over Purple Biotech and fixes it before they launch CM24+nivolumab+SOC into second line Pancreatic Cancer Action!). 🙏 These are some of the Fiercest People that I know. They aren't necessarily as fierce as my mom or Grandmothers were... but they are Plenty Fierce, and Strong Leaders whom I trust & hope take over their companies - or others - soon! 👍 The more women in control of healthcare (as my old friends at Biopharma Resource Groups, LLC and ZS know) ... the better! ✨ Old, White Men still have way too much Power in Corporate United States of America - Women represent half of the population, yet barely any are CEOs or Politicians - hopefully Healthcare Businesswomen’s Association can continue to change that, and companies like Johnson & Johnson can help address it by naming a female their next CEO. 🤝 If JNJ every wants to be fully past their Talc Powder manufacturer lawsuits, then they should empower more women to fix their massive company globally. 🍏 Cheers! 🏆 ~Jeffrey Jay Conroy 🥇 Global HC Analytics LLC, Founder 🥈 CNN has a nice summary here for those unfamiliar with the tragic JNJ Talc Powder Situation which has lingered for years & have yet to be resolved: https://lnkd.in/eKjn2Ant

🌟 Exciting Opportunity for Research Faculty and Innovators! 🌟 Do you have a technology or therapeutic that could help people or patients in need if only it could just get to market? The National Science Foundation's (NSF) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs offer unparalleled support for startups and small businesses focused on transforming their innovative research into market-ready products. To be eligible for the grant, your business must: Have fewer than 500 employees Be at least 50% owned by US citizens or permanent residents Conduct all work within the US (you can still use US based consultants and contractors) I can help with grant writing and even provide business consultation services to ensure you are eligible for application. With almost 15 years of biopharmaceutical experience, I can assist you in securing the funding you need to translate your technology into a thriving business. Contact me through LinkedIn or visit us at The Synaptic Gap (www.thesynapticgap.com) to see how we can support your journey from innovation to market! Don’t let prior business experience keep you from applying – scientists with an idea are encouraged to reach out. BIPOC and LGBTQ+ candidates are also strongly encouraged to apply. The Synaptic Gap is passionate about increasing access and participation from historically underserved populations. #Innovation #Entrepreneurship #StartupFunding #TechInnovation #NSFSeedFund #SBIR #STTR #SmallBusiness #ResearchAndDevelopment #GrantWriting #BusinessSupport #TheSynapticGap

Although all in transition in biopharma are facing challenges, it's essential to acknowledge that women and people of color have been disproportionately impacted. The industry remains predominantly White and male, particularly in leadership roles. According to industry data, executive teams in North America, Europe, and Australia are less than a third female, with only about one in three CEOs being female and persons of color. Moreover, the lack of racial diversity among the highest-ranking executives in pharma is concerning, with recent declines in representation. Addressing these disparities is crucial for fostering a more inclusive and equitable biopharma sector. #DiversityandInclusion #Biopharma #LeadershipRepresentation

Over the past year, I've had the privilege of attending numerous conferences and networking with investors and executives in the biotech industry. It's evident that securing funding in the current climate has been challenging. However, one consistent theme in my conversations with investors is the crucial importance of a strong and preferably experienced leadership team. Companies cannot just rely on exceptional science; they need the ability to articulate a commercial strategy, a clear vision, and strong operational expertise. This will make them attractive to investors looking for reliable and innovative partners in the high-risk biotech sector. A prime example is Third Arc Bio, which recently raised $165 million to develop oncology and autoimmune biologics. Their success can be attributed not only to their innovative science but also to their exceptional leadership team, led by former Johnson & Johnson executives. This underscores the critical role that experienced leadership plays in gaining investor confidence and driving biotech innovation forward. At GENerX Life, we are actively working with clients worldwide, coaching and advising on the leadership, skills, and competencies required to attract investment. Our expertise ensures that biotech companies are equipped with the right leaders and infrastructure to navigate today's competitive landscape. https://lnkd.in/eTi_TMyJ Visit us to learn more about our services - www.generx.life #Biotech #Leadership #Funding #Innovation #ExecutiveSearch #BiotechFunding #BusinessGrowth #GENerXLife #BiotechLeaders #Agileleaders

During our recent Annual Shareholder's Meeting, the question of gender diversity in our Board of Directors was raised, shedding light on the importance of representation and varied perspectives at the highest levels of decision-making. Christophe Weber, our President and CEO, emphasized the need for a more diverse Board that truly reflects the richness of our Executive Team and organization. With 53% female representation in our Executive Team, we are proud of our progress but acknowledge the room for improvement. Our CHRO Lauren Rusckowski Duprey, speaking on our people strategy, outlined our ambitious goals for gender parity. With a global workforce that is 52% female and 46% of senior leaders identifying as female or non-binary*, we are on a journey towards greater inclusivity. In Japan, where there is still progress to be made, initiatives like our Takeda Resource Groups and the leadership of Asuka Miyabashira inspire us to keep pushing for change. Join us on this journey towards embracing and celebrating diversity, while striving to give patients and our people equitable access to opportunities that help them achieve their full potential. #BetterHealth #BrighterFuture (*Disclosure: This data includes permanent and fixed-term employees.)  https://lnkd.in/gSCvMW-n

🌟 Synbias-Gemini Values: Teamwork and Continuous Improvement 🌟 At Synbias-Gemini, our culture is built on six core values: Teamwork, Continuous Improvement, Responsibility, Quality in Everything We Do, Trust, and Commitment. Today, we want to highlight two fundamental pillars of our organization: Teamwork and Continuous Improvement. Teamwork at Synbias-Gemini isn’t just about working together—it's about fostering an environment of mutual respect, open communication, and shared goals. Every member of our organization is valued, and we know that our collective strength drives our success in delivering life-saving APIs and cancer therapies. Continuous Improvement is more than a philosophy; it is an ongoing commitment. We invest in regular training programs, establish robust feedback systems, and promote a culture where every employee is encouraged to pursue betterment. This commitment ensures that we stay ahead in the global API market and remain leaders in cancer therapy development. This transformation journey was initiated by our shareholders and is led by Giles Farley, our Chairman of the Board and Interim CEO. However, achieving excellence is a collaborative effort that flows from the top down and from the bottom up, requiring the active engagement and dedication of every Synbias-Gemini team member. Together, we are committed to growing and making a difference. 🚀 #Teamwork #ContinuousImprovement #Responsibility #QualityInEverythingWeDo #Trust #Commitment #APIMarket #CancerTherapy #SynbiasGeminiValues #EmployeeEngagement #Leadership #SynbiasPharmaAG #GeminiPharmChemManhheimGmbH #SynbiasGemini #SynbiasGeminiMeetTheTeam

🚀 Transforming Leadership for Impact at AstraZeneca 🚀 ... Recently, we had the privilege of collaborating with AstraZeneca to tackle some critical challenges within their leadership and medical teams. Our journey began with a deep dive into team composition, purpose, and performance drivers. Key Insights: ➔ Right People, Right Purpose: Ensuring the team had the right members and a clear, meaningful purpose was our top priority. ➔ Driving Performance: A well-defined purpose empowers teams to excel, driving organisational performance. ➔ Purpose and Community: We emphasised the importance of creating a sense of belonging and community within the team to foster collaboration and innovation. For AstraZeneca, this meant focusing their leadership efforts on vital therapy areas, from curing cancer to addressing rare diseases. The result? A cohesive leadership team setting the standard for the entire organisation. We're proud to have been part of this transformative journey, helping AstraZeneca's leaders inspire purpose and drive excellence. #Leadership #Pharma #AstraZeneca #TeamPerformance #PurposeDriven #Innovation

🔬 From the labs of the University of Wisconsin-Madison to the leadership echelons of Lifescience Dynamics, Dr. Vicki Tsao is redefining the landscape of biotech innovation. With her extensive background in drug development and strategic biotechnology consultancy, she's not just part of the industry—she leads it. 👉 Read the full feature here: https://lnkd.in/eDKAdGV4 💬 Share your thoughts in the comments or tag someone who would find this inspiring! #WomenInSTEM #Leadership #WomenSupportingWomen